NYSE · Healthcare · Medical Devices · Ireland
Steris Plc is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
STERIS provides infection prevention products and services globally across three segments. Healthcare serves sterile processing departments with consumables, equipment, and maintenance services. Applied Sterilization Technologies offers contract sterilization and laboratory testing to medical device and pharmaceutical manufacturers. Life Sciences supplies biopharmaceutical and medical device manufacturers with consumables, equipment, and services.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Steris Plc stock.
Slightly overvalued: intrinsic value $190.97 per share, market price $227.12, margin of safety -18.9% (as of 2026-10-30).
Discounting its cash flows at 9.2% (average of 3 methods) values the shares at $190.97; the price of $227.12 is 19% above that value, and 75% of that value comes from beyond year five.
Leak Score: 58/100 on 12 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
20 more in this industry show a wider margin of safety.
STE is slightly overvalued (as of the 2026-10-30 close). Discounting its cash flows at 9.2% (average of 3 methods) values the shares at $190.97; the price of $227.12 is 19% above that value, and 75% of that value comes from beyond year five.
$190.97 per share (as of the 2026-10-30 close), against a market price of $227.12. That is a margin of safety of -18.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
58 out of 100, which we rate "Weak Signal", on 12 of 12 value investing signals.